Incannex Healthcare Inc
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
IXHL$2.19-2.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, 2025 | June 30, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $6,711 | $5,858 |
| Prepaid expenses and other assets | 416 | 507 |
| Assets pledged as security for short-term debt | 1,397 | - |
| Research and Development (“R&D”) tax incentive receivable | 7,105 | 9,837 |
| Total current assets | 15,629 | 16,202 |
| Property, plant and equipment, net | 277 | 472 |
| Operating lease right-of-use assets | 291 | 373 |
| Total assets | $16,197 | $17,047 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Trade and other payables | $1,067 | $612 |
| Accrued expenses and other current liabilities | 4,718 | 4,845 |
| Short-term debt | 1,397 | - |
| Operating lease liabilities, current | 186 | 163 |
| Total current liabilities | 7,368 | 5,620 |
| Operating lease liabilities, non-current | 104 | 210 |
| Long-term debt | - | - |
| Warrant liabilities | 1,322 | - |
| Convertible rights | - | - |
| Total liabilities | 8,794 | 5,830 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value – shares 100,000,000 authorized; 17,785,235 and 17,642,832 shares issued and outstanding at March 31, 2025 and June 30, 2024 respectively | 2 | 2 |
| Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at March 31, 2025 and June 30, 2024, respectively | - | - |
| Additional paid-in capital | 136,849 | 125,218 |
| Accumulated deficit | (125,953) | (110,671) |
| Foreign currency translation reserve | (3,495) | (3,332) |
| Total stockholders’ equity | 7,403 | 11,217 |
| Total liabilities and stockholders’ equity | $16,197 | $17,047 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.